Ocera Therapeutics
VerifiedBiopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$42m (Public information from Nov 2017)
Palo Alto California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor investor investor investor investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
$42.0m Valuation: $42.0m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Recent News about Ocera Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.